greeksoup/ stock research

Altria Group (MO) FY2025 results: revenue $23.3 billion, down 3.1% on the year

Altria Group, Inc. (MO) reported revenue of $23.3 billion for fiscal 2025, the year ended 31 December 2025, down 3.1% on the year before. Net income was $6.9 billion, down 38.3%, and diluted earnings per share $4.12. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2026.

Revenue
$23.3 billion
-3.1% on the year
FY2018FY2025
Operating margin
42.5%
46.8% a year earlier
FY2018FY2025
Net income
$6.9 billion
-38.3% on the year
FY2018FY2025
Diluted EPS
$4.12
-37.0% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The year in brief

What management said about the year

Guidance figures: 1 raised, 4 new, 4 kept.

  • Full-year adjusted EPS rose 4.4%: Full-year adjusted diluted EPS rose 4.4% to $5.42. Management tied the rise to higher adjusted OCI, fewer shares and a lower adjusted tax rate, partly offset by lower pension income and higher financing costs.
  • Quarterly smokeable revenue fell on volume: Smokeable net revenues fell 2.7% in the fourth quarter on lower shipment volume and higher promotional investments, partly offset by higher pricing.
  • Quarterly oral margin fell on SG&A: Fourth-quarter adjusted oral OCI fell 4.6% and margin fell 5.0 points to 64.5%, on higher SG&A and lower volume and mix, partly offset by pricing.
  • Discount brands gained share: Fourth-quarter cigarette discount share reached 32.9%, up 2.6 points, which management linked to continued discretionary income pressures on ANCs.
  • E-vapor impairments drove charges: Asset impairment, exit and implementation costs were $1.3 billion in the fourth quarter ($0.61 per share) and $2.2 billion for 2025, mostly from e-vapor goodwill and intangibles.
Read the Q4 FY2025 earnings call summary

From this 10-K

Altria sells tobacco and nicotine products to United States consumers aged 21 and over. It describes its direction as Moving Beyond Smoking: transitioning adult smokers to smoke-free products, competing for existing smoke-free nicotine consumers, and looking for growth beyond the United States and beyond nicotine. It operates primarily within the United States and generates substantially all of its revenue from domestic customers. At 31 December 2025 the reportable segments were smokeable products, oral tobacco products and e-vapor products.

Altria Group, Inc., the 10-K for 2025

Altria sells tobacco and nicotine products to United States consumers aged 21 and over. It describes its direction as Moving Beyond Smoking: transitioning adult smokers to smoke-free products, competing for existing smoke-free nicotine consumers, and looking for growth beyond the United States and beyond nicotine. It operates primarily within the United States and generates substantially all of its revenue from domestic customers. At 31 December 2025 the reportable segments were smokeable products, oral tobacco products and e-vapor products.

The operating companies

Philip Morris USA makes and sells cigarettes. John Middleton, a subsidiary of Philip Morris USA, makes and sells machine-made large cigars. UST, through U.S. Smokeless Tobacco Company, makes and sells moist smokeless tobacco. Helix Innovations and its foreign affiliates make and sell oral nicotine pouches. NJOY makes and sells e-vapor products. Altria Group Distribution Company provides domestic sales and distribution to the operating companies, and Altria Client Services provides legal, regulatory, research and product development, consumer engagement, finance, human resources and external affairs support.

What sells and how much

Philip Morris USA is the largest cigarette company in the United States, and Marlboro, its principal brand, has been the largest-selling cigarette brand in the country for over 50 years. Cigarette shipment volume was 61.8 billion units in 2025, down 10.0% on 2024. Middleton's principal cigar brand is Black & Mild, and cigar shipment volume was approximately 1.8 billion units in 2025, up 1.8%. The oral tobacco segment covers the premium moist smokeless brands Copenhagen and Skoal, the value brand Red Seal, and on! oral nicotine pouches from Helix; its shipment volume was 732.4 million units in 2025, down 5.5%. NJOY's tobacco and menthol e-vapor products are covered by marketing granted orders from the Food and Drug Administration, but its principal product, NJOY ACE, is subject to an exclusion order and cease-and-desist orders from the U.S. International Trade Commission prohibiting its importation and sale in the United States.

The heated tobacco joint venture

At 31 December 2025 the company owned a 75% economic interest in Horizon Innovations, a joint venture with a subsidiary of Japan Tobacco holding the other 25%. Horizon handles United States marketing and commercialisation of heated tobacco stick products owned by either party, meaning a device that heats a consumable without burning it plus a consumable that meets the statutory definition of a cigarette. On authorisation by the Food and Drug Administration it becomes the exclusive route through which the two parties commercialise such products in the United States, with Japan Tobacco's subsidiary supplying Ploom devices and Philip Morris USA manufacturing Marlboro consumables. As of 25 February 2026 the joint venture had no products in the United States market.

Supply, distribution and competition

The tobacco subsidiaries sell principally to wholesalers, including distributors, and to large retail organisations such as chain stores. Philip Morris USA buys most of its burley and flue-cured leaf directly from domestic growers under a contract growing programme, plus some through leaf merchants; U.S. Smokeless Tobacco buys dark fire-cured, dark air-cured and burley leaf from domestic growers under its own contract programme; Middleton buys through leaf merchants without a growing programme; and Helix and NJOY buy tobacco-derived nicotine materials from suppliers. The market is described as highly competitive, turning on brand recognition and loyalty, product quality, taste, price, product development, marketing, packaging, distribution and promotion, with allowances, incentive items, price promotions, coupons and discounts used where the law permits.

Investments and people

The company holds equity method investments in Anheuser-Busch InBev and Cronos Group, accounted for with a one-quarter lag. It employed approximately 5,900 people at 31 December 2025, twenty-six percent of them hourly manufacturing employees who belong to labour unions under collective bargaining agreements, with long-term agreements that settle bargaining disputes through binding arbitration. The company notes that decreasing social acceptance of tobacco use may affect its ability to attract and keep staff, and says it manages that by targeting total compensation above the peer companies it competes with for talent.

From Altria Group's annual report on Form 10-K for the year ended 31 December 2025. The filing

Written from the 10-K filed 25 February 2026: read the full 10-K.

The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025

Income statement (profit and loss)

$ millionFY2025FY2024FY2023On the yearLast 8 years
Revenue23,27924,01824,483-3.1%
Cost of revenue5,5976,0776,218-7.9%
Gross profit14,54214,36714,284+1.2%
Gross margin62.5%59.8%58.3%
Research and development195208220-6.2%
Operating income9,89911,24111,547-11.9%
Operating margin42.5%46.8%47.2%
Interest expense1,1771,1241,149+4.7%
Pre-tax income9,38913,65810,928-31.3%
Income tax2,4422,3942,798+2.0%
Effective tax rate26.0%17.5%25.6%
Net income6,94711,2648,130-38.3%
Net margin29.8%46.9%33.2%
Diluted EPS$4.12$6.54$4.57-37.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2025FY2024FY2023On the yearLast 8 years
Operating cash flow9,2908,7539,287+6.1%
Capital expenditure216142196+52.1%
Free cash flow9,0748,6119,091+5.4%
Free cash flow margin39.0%35.9%37.1%
Cash from investing-3412,175-1,283
Cash from financing-7,615-11,491-8,374
Depreciation and amortisation266286272-7.0%
Buybacks1,0003,4001,000-70.6%
Dividends paid6,9606,8456,779+1.7%
Dividend per share$4.16$4.00$3.84+4.0%
Diluted shares, weighted1,683m1,718m1,777m-2.0%
Shares outstanding at period end1,674m1,691m1,763m-1.0%

Balance sheet

$ millionFY2025FY2024FY2023On the yearLast 8 years
Shareholders' equity-3,502-2,238-3,540
Non-controlling interest50.050.050.00.0%
Short-term borrowings0.00.00.0
Debt25,70924,92626,233+3.1%
Other liabilities12,76012,43915,827+2.6%
Total liabilities and equity35,01735,17738,570-0.5%
Fixed assets1,7101,6171,652+5.8%
Goodwill5,7876,9456,791-16.7%
Intangible assets11,87612,97313,686-8.5%
Cash and equivalents4,4743,1273,686+43.1%
Receivables26317771.0+48.6%
Inventory1,0701,0801,215-0.9%
Other assets9,8379,25811,469+6.3%
Total assets35,01735,17738,570-0.5%

10-K for the year ended 31 December 2025, filed 25 February 2026: the filing.